![Robert Gagnon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Gagnon
Finanzdirektor/CFO bei
OPUS GENETICS, INC.
Vermögen: 3 Mio $ am 31.05.2026
Profil
Robert E.
Gagnon is Secretary, Treasurer & Director at KD Scientific, Inc. He is Independent Director at Harvard Bioscience, Inc. starting in 2025, Independent Director at Purple Biotech Ltd. since 2021, Independent Director at Bone Biologics Corp.
since 2024, and Chief Financial & Accounting Officer at Opus Genetics, Inc. starting in 2025.
Former roles include Director at Verastem, Inc. from 2022 to 2026, Chief Financial Officer, Treasurer & Executive VP at Clean Harbors, Inc. from 2012 to 2013, CAO, VP-Business Planning & Controller at Biogen, Inc. in 2012, Chief Financial Officer at Harvard Bioscience, Inc. from 2015 to 2018, Chief Financial & Business Officer at Verastem, Inc. from 2019 to 2022, Partner at Gurnet Point Capital LLC from 2022 to 2023, Chief Financial Officer at Remix Therapeutics, Inc. from 2023 to 2025, and Manager-Global Orthobiologics R&D at Zimmer Biomet, Inc. from 2013 to 2017.
Education includes undergraduate studies at Bentley University and an MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OPUS GENETICS, INC. 0.73% | 23.04.2026 | 592’158 ( 0.73% ) | 3 Mio $ | 31.05.2026 |
VERASTEM, INC. 0.07% | 24.03.2026 | 41’678 ( 0.07% ) | 180 466 $ | 31.05.2026 |
| 09.06.2026 | 11’000 ( 0.24% ) | 64 680 $ | 31.05.2026 | |
PURPLE BIOTECH LTD. 0.15% | 18.03.2026 | 3’062’500 ( 0.15% ) | 10 933 $ | 31.05.2026 |
BONE BIOLOGICS CORP. -.--% | 23.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Robert Gagnon
| Unternehmen | Position | Beginn |
|---|---|---|
| PURPLE BIOTECH LTD | Direktor/Vorstandsmitglied | 03.03.2021 |
| BONE BIOLOGICS CORPORATION | Direktor/Vorstandsmitglied | 08.01.2024 |
| HARVARD BIOSCIENCE, INC. | Direktor/Vorstandsmitglied | 16.07.2025 |
| OPUS GENETICS, INC. | Finanzdirektor/CFO | 02.09.2025 |
KD Scientific, Inc.
 KD Scientific, Inc. Medical SpecialtiesHealth Technology Develops and manufactures syringe pumps used by research laboratory markets globally | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert Gagnon
| Unternehmen | Position | Ende |
|---|---|---|
| VERASTEM, INC. | Direktor/Vorstandsmitglied | 21.05.2026 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Finanzdirektor/CFO | 30.06.2025 |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Corporate Officer/Principal | 01.06.2023 |
| VERASTEM, INC. | Finanzdirektor/CFO | 31.10.2022 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Robert Gagnon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Clean Harbors, Inc.
 Clean Harbors, Inc. Environmental ServicesIndustrial Services Provides environmental and industrial waste recycling services | Industrial Services |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Harvard Bioscience, Inc.
 Harvard Bioscience, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets apparatus and scientific instruments | Health Technology |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology Develops and manufactures syringe pumps used by research laboratory markets globally | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Purple Biotech Ltd.
 Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bone Biologics Corp.
 Bone Biologics Corp. Medical SpecialtiesHealth Technology Develops ortho biologic products | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Zimmer Biomet, Inc. |
